Mometason-Mepha Nasenspray, Suspension

7680632480024 CH-63248 suspension
Mometason-Mepha Nasenspray, Suspension
Mometason-Mepha Nasenspray, Suspension
Mometason-Mepha Nasenspray, Suspension
1 / 3
google

Article details

Package size
3 x 140
Selling units
420
Measure
Einzeldose(n)
Galenic form
suspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
03/06/2024
Patient information leaflet
Français
03/06/2024
Patient information leaflet
Italien
03/06/2024
Summary of Product Characteristics
Allemand
03/06/2024
Summary of Product Characteristics
Français
03/06/2024
Summary of Product Characteristics
Italien
03/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
20.0 UG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 37.85
Specialties list
Yes
Generic
Yes
SL addition date: 01/11/2017

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
63248
Drug name
Mometason-Mepha Nasenspray, Suspension
Galenic form
NASSS
ATC Code
R01AD09
Authorization status
Z
Dispensing category
B
First authorization
07/02/2014
Authorization expiration date
31/12/9999
IT Number
12.02.3.
Domain
Human medicine
Field of application
Rhinitis, Nasenpolypen

Package details

Description (FR)
MOMETASON Mepha spray nasal 50 mcg 3 x 140 dos
Description (DE)
MOMETASON Mepha Nasenspray 50 mcg 3 x 140 Dos
Market launch
07/02/2014
Narcotic (BTM)
No

Original drug

Nasonex, Dosier-Nasenspray
GTIN: 7680541890365
CHF 18.45
View original

Other package sizes (1)

MOMETASON Mepha spray nasal 50 mcg 140 dos
140 EINZ
GTIN: 7680632480017
View